Author:
Dogra M. R.,Katoch Deeksha
Reference22 articles.
1. Abu El-Asrar AM, Jestaneiah S, Al-Serhani AM. Regression of aneurysmal dilatations in a case of idiopathic retinal vasculitis, aneurysms and neuroretinitis (IRVAN) associated with allergic fungal sinusitis. Eye (Lond). 2004;18:197–9.
2. Akesbi J, Brousseaud FX, Adam R, Rodallec T, Nordmann JP. Intravitreal bevacizumab (Avastin) in idiopathic retinitis, vasculitis, aneurysms and neuroretinitis. Acta Ophthalmol. 2010;88:e40–1.
3. Basha M, Brown GC, Palombaro G, Shields CL, Shields JA. Management of IRVAN syndrome with observation. Ophthalmic Surg Lasers Imaging Retina. 2014;45:e18–22.
4. Chang TS, Aylward GW, Davis JL, Mieler WF, Oliver GL, Maberly AL, et al. Idiopathic retinal vasculitis, aneurysms, and neuro-retinitis: the Retinal Vasculitis Study Group. Ophthalmology. 1995;102:1089–97.
5. Cheema RA, Al-Askar E, Cheema HR. Infliximab therapy for idiopathic retinal vasculitis, aneurysm, and neuroretinitis syndrome. J Ocul Pharmacol Ther. 2011;27:407–10.